|
|
|
|
LEADER |
00000cam a22000007a 4500 |
001 |
SCIDIR_on1353838364 |
003 |
OCoLC |
005 |
20231120010717.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
221209s2023 enk o 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|c YDX
|d UKMGB
|d OPELS
|d OCLCF
|d OCLCO
|
015 |
|
|
|a GBC180616
|2 bnb
|
016 |
7 |
|
|a 020202639
|2 Uk
|
020 |
|
|
|a 9780128226261
|q (electronic bk.)
|
020 |
|
|
|a 0128226269
|q (electronic bk.)
|
020 |
|
|
|z 9780128226209
|
020 |
|
|
|z 012822620X
|
035 |
|
|
|a (OCoLC)1353838364
|
050 |
|
4 |
|a RC271.I45
|
082 |
0 |
4 |
|a 616.99406
|2 23
|
245 |
0 |
0 |
|a NK cells in cancer immunotherapy :
|b successes and challenges /
|c edited by Anahid Jewett, Yuman Fong.
|
260 |
|
|
|a London :
|b Academic Press,
|c 2023.
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|2 rdacontent
|
337 |
|
|
|a computer
|2 rdamedia
|
338 |
|
|
|a online resource
|2 rdacarrier
|
490 |
0 |
|
|a Sensitizing agents for cancer resistant to cell mediated immunotherapy ;
|v v. 4
|
500 |
|
|
|a Includes index.
|
650 |
|
0 |
|a Cancer
|x Immunotherapy.
|
650 |
|
0 |
|a Killer cells.
|
650 |
|
6 |
|a Cancer
|x Immunoth�erapie.
|0 (CaQQLa)201-0168739
|
650 |
|
7 |
|a Cancer
|x Immunotherapy
|2 fast
|0 (OCoLC)fst00845386
|
650 |
|
7 |
|a Killer cells
|2 fast
|0 (OCoLC)fst00987504
|
700 |
1 |
|
|a Jewett, Anahid.
|
700 |
1 |
|
|a Fong, Yuman.
|
776 |
0 |
8 |
|i ebook version :
|z 9780128226261
|
776 |
0 |
8 |
|c Original
|z 012822620X
|z 9780128226209
|w (OCoLC)1190814229
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128226209
|z Texto completo
|